Danielle Burkhalter is CHRO at Surgery Partners, Inc. (SGRY). They have made 12 open-market trades across 1 company since 2023, most recently 2026-03-13.
CIK 0001966798
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGRY | 76,864 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-03-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGRY | SELL | 2026-03-13 | 2026-03-16 | $12.83 | $45K | -4.4% | +6.5% | +22.1% |
| SGRY | SELL | 2026-03-06 | 2026-03-09 | $13.60 | $105K | -8.7% | -4.2% | +4.8% |
| SGRY | SELL | 2025-03-14 | 2025-03-17 | $23.78 | $2K | -0.3% | -12.8% | -4.2% |
| SGRY | SELL | 2025-03-10 | 2025-03-13 | $24.14 | $30K | +1.2% | -10.8% | -3.1% |
| SGRY | SELL | 2025-02-04 | 2025-02-04 | $25.68 | $4K | +0.6% | -6.0% | -8.7% |
| SGRY | SELL | 2024-06-12 | 2024-06-13 | $26.39 | $158K | -5.0% | +3.8% | +22.8% |
| SGRY | SELL | 2024-03-11 | 2024-03-13 | $29.66 | $7K | +0.3% | -7.6% | -12.7% |
| SGRY | SELL | 2024-03-04 | 2024-03-06 | $30.41 | $18K | -10.8% | -11.1% | -16.4% |
| SGRY | SELL | 2024-02-14 | 2024-02-16 | $33.42 | $6K | -7.6% | -18.0% | -21.2% |
| SGRY | SELL | 2024-02-06 | 2024-02-08 | $32.24 | $5K | -0.7% | -10.7% | -18.0% |
| SGRY | SELL | 2023-03-13 | 2023-03-15 | $30.83 | $18K | +5.2% | +21.7% | +29.0% |
| SGRY | SELL | 2023-01-31 | 2023-03-06 | $33.60 | $30K | -3.2% | +4.4% | +17.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.